Xingwei D. Sui
Experienced in Small Lymphocytic Lymphoma (SLL)

Dr. Xingwei D. Sui

Hematology | Oncology
Swedish Medical Center
Providence Regional Cancer System - Aberdeen
954 Anderson Drive, Suite 102, 
Aberdeen, WA 
Accepting New Patients
Offers Telehealth

Experienced in Small Lymphocytic Lymphoma (SLL)
Swedish Medical Center
Providence Regional Cancer System - Aberdeen
954 Anderson Drive, Suite 102, 
Aberdeen, WA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dr. Sui earned a medical degree from Qingdao University, China, and a Ph.D. from the University of Tokyo, Japan. He conducted postdoctoral research in hematology at Vanderbilt University, an internal medicine residency at the University of Tennessee, and a medical oncology fellowship at the Fred Hutchinson Cancer Research Center and the University of Washington. He is board certified in internal medicine and medical oncology. He was an associate professor at Shangdong. Dr. Sui believes in treating his patients as if they were his own family members.

Dr. Sui is rated as an Experienced provider by MediFind in the treatment of Small Lymphocytic Lymphoma (SLL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Lung Cancer, Pleuropulmonary Blastoma, and Large-Cell Immunoblastic Lymphoma.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Qingdao University , 1984
Residency
Baptist Hospital , 2003
Specialties
Hematology
Oncology
Licenses
Internal Medicine in WA
Board Certifications
American Board Of Internal Medicine
Fellowships
University of Washington Department Hematology Oncology Fellowship , 2005
Hospital Affiliations
Grays Harbor Community Hospital
Summit Pacific Medical Center
Providence Centralia Hospital
Providence St Peter Hospital
Languages Spoken
English
Japanese
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Lifewise

Accepted plan types not found. Please verify directly with the provider.

Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PacificSource
  • PPO
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Prominence Health
  • EPO
  • PPO
Regence
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Providence Regional Cancer System - Aberdeen
954 Anderson Drive, Suite 102, Aberdeen, WA 98520
Call: 360-533-6906
Other Locations
Providence Regional Cancer System - Lacey
4525 3rd Avenue Southeast, Suite 200, Lacey, WA 98503
Call: 360-754-3934
Providence St. Peter Hospital
413 Lilly Road Northeast, Olympia, WA 98506
Call: 360-491-9480
Providence Centralia Hospital
914 South Scheuber Road, Centralia, WA 98531
Call: 360-736-2803

Additional Areas of Focus

Dr. Sui has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Thalassemia
Anemia
Langerhans Cell Histiocytosis
Hereditary Spherocytosis
Hemochromatosis
Histiocytosis
Breast Cancer
HELLP Syndrome
Splenomegaly
Thrombotic Thrombocytopenic Purpura
Purpura
Thrombocytopenia
Iron Deficiency Anemia
Leukocytosis
View 4 Less Areas of Focus-

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

Phase 3 Randomized Study Comparing X-396 (Ensartinib) to Crizotinib in Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients
Phase 3 Randomized Study Comparing X-396 (Ensartinib) to Crizotinib in Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients
Enrollment Status: Active_not_recruiting
Publish Date: October 14, 2025
Intervention Type: Drug
Study Drugs: X-396 (Ensartinib), Crizotinib
Study Phase: Phase 3
A Phase 1 / 2, Open-Label, Multi-Arm Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of AGEN1884 in Combination With AGEN2034 in Subjects With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors
A Phase 1 / 2, Open-Label, Multi-Arm Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of AGEN1884 in Combination With AGEN2034 in Subjects With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors
Enrollment Status: Completed
Publish Date: July 05, 2023
Intervention Type: Drug
Study Drugs: AGEN-2034 PD-1 Antibody, AGEN-1884 CTLA4 Antibody
Study Phase: Phase 1/Phase 2
Modular Phase 2 Study to Link Combination Immune-therapy to Patients With Advanced Solid and Hematologic Malignancies. Module 9: PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies.
Modular Phase 2 Study to Link Combination Immune-therapy to Patients With Advanced Solid and Hematologic Malignancies. Module 9: PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies.
Enrollment Status: Completed
Publish Date: May 27, 2022
Intervention Type: Biological
Study Phase: Phase 2
View 2 Less Clinical Trials

3 Total Publications

Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study.
Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study.
Journal: Journal for immunotherapy of cancer
Published: October 05, 2024
View All 3 Publications
Similar Doctors
Daniel M. Byrd
Advanced in Small Lymphocytic Lymphoma (SLL)
Dr. Daniel M. Byrd
Oncology | Hematology
Advanced in Small Lymphocytic Lymphoma (SLL)
Dr. Daniel M. Byrd
Oncology | Hematology

Providence Regional Cancer System - Centralia

2015 Cooks Hill Road, Suite 200, 
Centralia, WA 
 (22.4 miles away)
360-330-8939
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Byrd is board-certified in internal medicine, oncology and hematology. He completed a fellowship in hematology/oncology at Oregon Health & Science University, where he also completed his residency and internship in internal medicine. He received his medical degree from the University of Texas Southwestern Medical School in Dallas. Dr. Byrd is rated as a Distinguished provider by MediFind in the treatment of Small Lymphocytic Lymphoma (SLL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Familial Colorectal Cancer, Neuroendocrine Tumor, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration.

Advanced in Small Lymphocytic Lymphoma (SLL)
Dr. Prakash Thapaliya
Hematology Oncology | Oncology | Hematology
Advanced in Small Lymphocytic Lymphoma (SLL)
Dr. Prakash Thapaliya
Hematology Oncology | Oncology | Hematology

Kaiser Foundation Health Plan Of Washington

700 Lilly Rd Ne, 
Olympia, WA 
 (3.2 miles away)
360-923-7000
Languages Spoken:
English, Arabic, Filipino, Hindi, Japanese, Korean, Nepali, Punjabi, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Prakash Thapaliya is a Hematologist Oncology specialist and an Oncologist in Olympia, Washington. Dr. Thapaliya is rated as an Advanced provider by MediFind in the treatment of Small Lymphocytic Lymphoma (SLL). His top areas of expertise are Multiple Myeloma, Familial Colorectal Cancer, Breast Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Thapaliya is currently accepting new patients.

Experienced in Small Lymphocytic Lymphoma (SLL)
Dr. Ahmad A. Fora
Oncology | Hematology Oncology | Hematology
Experienced in Small Lymphocytic Lymphoma (SLL)
Dr. Ahmad A. Fora
Oncology | Hematology Oncology | Hematology

American Oncology Partners PA

141 Lilly Rd Ne, 
Olympia, WA 
 (3.0 miles away)
360-413-8880
Languages Spoken:
English, Arabic, Bosnian, Filipino, Korean, Punjabi
See accepted insurances
Accepting New Patients
Offers Telehealth

Ahmad Fora is an Oncologist and a Hematologist Oncology provider in Olympia, Washington. Dr. Fora is rated as an Advanced provider by MediFind in the treatment of Small Lymphocytic Lymphoma (SLL). His top areas of expertise are Essential Thrombocythemia, Thrombocytopenia, Acute Mountain Sickness, and Monoclonal Gammopathy of Undetermined Significance (MGUS). Dr. Fora is currently accepting new patients.

VIEW MORE SMALL LYMPHOCYTIC LYMPHOMA (SLL) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sui's expertise for a condition
ConditionClose
    • Distinguished
    • Chronic B-Cell Leukemia (CBCL)
      Dr. Sui is
      Distinguished
      . Learn about Chronic B-Cell Leukemia (CBCL).
      See more Chronic B-Cell Leukemia (CBCL) experts
    • Chronic Lymphocytic Leukemia (CLL)
      Dr. Sui is
      Distinguished
      . Learn about Chronic Lymphocytic Leukemia (CLL).
      See more Chronic Lymphocytic Leukemia (CLL) experts
    • Colorectal Cancer
      Dr. Sui is
      Distinguished
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    • Familial Colorectal Cancer
      Dr. Sui is
      Distinguished
      . Learn about Familial Colorectal Cancer.
      See more Familial Colorectal Cancer experts
    • Large-Cell Immunoblastic Lymphoma
      Dr. Sui is
      Distinguished
      . Learn about Large-Cell Immunoblastic Lymphoma.
      See more Large-Cell Immunoblastic Lymphoma experts
    • Lung Cancer
      Dr. Sui is
      Distinguished
      . Learn about Lung Cancer.
      See more Lung Cancer experts
    View All 10 Distinguished Conditions
    • Advanced
    • Acute Hepatic Porphyria (AHP)
      Dr. Sui is
      Advanced
      . Learn about Acute Hepatic Porphyria (AHP).
      See more Acute Hepatic Porphyria (AHP) experts
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Sui is
      Advanced
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Myeloid Leukemia (AML)
      Dr. Sui is
      Advanced
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • Adult Immune Thrombocytopenia
      Dr. Sui is
      Advanced
      . Learn about Adult Immune Thrombocytopenia.
      See more Adult Immune Thrombocytopenia experts
    • Adult Soft Tissue Sarcoma
      Dr. Sui is
      Advanced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Sui is
      Advanced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    View All 48 Advanced Conditions
    • Experienced
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Sui is
      Experienced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Agranulocytosis
      Dr. Sui is
      Experienced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • Alveolar Soft Part Sarcoma
      Dr. Sui is
      Experienced
      . Learn about Alveolar Soft Part Sarcoma.
      See more Alveolar Soft Part Sarcoma experts
    • Ampullary Cancer
      Dr. Sui is
      Experienced
      . Learn about Ampullary Cancer.
      See more Ampullary Cancer experts
    • Anal Cancer
      Dr. Sui is
      Experienced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • Anemia
      Dr. Sui is
      Experienced
      . Learn about Anemia.
      See more Anemia experts
    View All 100 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.